Dyclone and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Dyclone (dyclonine hydrochloride), especially for people who are female, 60+ old, also take Synthroid, and have Pain.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Dyclone. It is created by eHealthMe based on reports of 182 people who have side effects when taking Dyclone from the FDA, and is updated regularly.

What is Dyclone?

Dyclone has active ingredients of dyclonine hydrochloride. eHealthMe is studying from 186 Dyclone users. Check the latest studies of Dyclone.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,754 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.



On Jul, 13, 2026

182 people reported to have side effects when taking Dyclone.
Among them, 15 people (8.24%) have Hypersensitivity.

Could Dyclone cause Hypersensitivity?

Among these 15 people:

What is the gender of people who have Hypersensitivity when taking Dyclone? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Hypersensitivity when taking Dyclone? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 12.5 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 87.5 %

What are other drugs people take besides Dyclone? *

  1. Benadryl: 12 people, 80.00%
  2. Synthroid: 12 people, 80.00%
  3. Kenalog: 11 people, 73.33%
  4. Codeine: 11 people, 73.33%
  5. Omnaris: 11 people, 73.33%
  6. Kadian: 11 people, 73.33%
  7. Enbrel: 11 people, 73.33%
  8. Remicade: 11 people, 73.33%
  9. Restasis: 11 people, 73.33%
  10. Rituxan: 11 people, 73.33%

What are other side effects people have besides Hypersensitivity? *

  1. Joint Pain: 12 people, 80.00%
  2. Drug Ineffective: 12 people, 80.00%
  3. Leukopenia (less number of white blood cells in blood): 11 people, 73.33%
  4. Pneumonia Viral: 11 people, 73.33%
  5. High Blood Cholesterol: 11 people, 73.33%
  6. Infection: 11 people, 73.33%
  7. Joint Swelling: 11 people, 73.33%
  8. Liver Function Test Abnormal: 11 people, 73.33%
  9. Drug Intolerance (drug sensitivity): 11 people, 73.33%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 11 people, 73.33%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 73.33%
  2. Pain: 11 people, 73.33%
  3. Joint Pain: 6 people, 40.00%
  4. Blood Immunoglobulin E Increased: 2 people, 13.33%
  5. Asthma: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dyclone and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dyclone:

Hypersensitivity treatments and more:

How severe was Hypersensitivity and when was it recovered:

Expand to all the drugs that have ingredients of dyclonine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dyclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Browse all the conditions that are associated with Hypersensitivity:


How the study uses the data?

The study uses data from the FDA. It is based on dyclonine hydrochloride (the active ingredients of Dyclone) and Dyclone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: